ACC.26前瞻：会议日程抢先一览，中国学者成果将再次亮相

ACC.26

北京时间3月28日至31日，由美国心脏病学会（ACC）举办的心血管领域盛会——ACC.26学术会议将在美国新奥尔良隆重举行。作为全球顶尖心血管学术盛会，ACC年会将汇聚来自全球的20，000余名专业人士，通过互动式研讨、学术交流及产品博览会等形式，推动心血管领域的创新发展。

本次会议特别值得关注的是，多位中国心血管研究专家将报告其团队的重要研究成果，展现中国学者在国际顶尖学术舞台上的影响力。其中，中国人民解放军东部战区总医院唐春香教授与郭翔教授、中国医学科学院阜外医院康连鸣教授将分别报告其团队在冠状动脉疾病无创评估、人群筛查及心肌病治疗领域的前沿成果。

具体日程让我们一起先睹为快！

01

重要指南更新值得关注

除了前沿临床研究，本次会议将发布：

·2026年血脂异常管理指南

·2026年急性肺栓塞指南

这些指南将为临床实践提供重要参考，促进心血管疾病诊疗的标准化和规范化。

02

最新突破性临床试验（LBCT）

LBCT I

北京时间：3月28日 23:30-00:30

Ultrasound-Facilitated Catheter-Directed Thrombolysis Vs Anticoagulation Alone For Acute Intermediate-High-Risk Pulmonary Embolism: Primary Results of the HI-PEITHO Randomized Clinical Trial

急性中高危肺栓塞超声辅助导管导向溶栓对比单纯抗凝治疗：HI-PEITHO随机临床试验主要结果

汇报人：Stavros V. Konstantinides

Outcomes in Patients With Atrial Fibrillation Randomized to Receive Left Atrial Appendage Closure or Oral Anticoagulation: Primary Results of the CHAMPION-AF Clinical Trial

比较随机接受左心耳封堵术或口服抗凝治疗的房颤患者的结局：CHAMPION-AF临床试验的主要结果

汇报人：Saibal Kar

Primary Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction (STEMI) Without Cardiogenic Shock: Results From the STEMI-Door to Unload Randomized Clinical Trial

无心源性休克前壁ST段抬高型心肌梗死的早期左心室减负荷治疗：STEMI-Door to Unload随机临床试验结果

汇报人：Navin Kapur

LBCT II

北京时间：3月29日 5:45-6:45

Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled HypertensionKARDINAL

研究：评估Tonlamarsen治疗未控制高血压的2期临床试验

汇报人：Luke Laffin

Evolocumab in Patients Without Significant Atherosclerosis: Results From VESALIUS-CV

依洛尤单抗在无显著动脉粥样硬化患者中的应用：VESALIUS-CV研究结果

汇报人：Nicholas Marston

Intensive Low-Density Lipoprotein Cholesterol Targeting in Patients With Atherosclerotic Cardiovascular Disease

动脉粥样硬化性心血管疾病患者强化低密度脂蛋白胆固醇目标值探索

汇报人：Yong-Joon Lee

DASH-Patterned Groceries to Reduce Blood Pressure Among Adults With Treated Hypertension: Results From the GoFreshRx Randomized Clinical Trial

为经治疗的高血压成人提供DASH模式食品以降低血压：GoFreshRx随机临床试验结果

汇报人：Stephen Paul Juraschek

LBCT III

北京时间：3月29日 22:30-23:30

Controlled Trial of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3)

高危冠状动脉介入治疗中经皮左心室减负荷技术的对照试验：CHIP-BCIS3研究

汇报人：Divaka Perera

A Large-Scale, Global Randomized Trial of Coronary Physiology Derived From Conventional Angiography Compared With An Invasive Pressure Wire-Based Approach to Guide Percutaneous Coronary Intervention

一项大规模全球随机试验：比较基于常规造影衍生的冠状动脉生理学与基于有创压力导丝的方法指导经皮冠状动脉介入治疗

汇报人：Ajay J. Kirtane

A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina- ORBITA-CTO Trial

稳定型心绞痛患者慢性完全闭塞病变经皮冠状动脉介入治疗的随机、安慰剂对照试验——ORBITA-CTO试验

汇报人：Sarosh A. Khan

Fractional Flow Reserve or 3d-quantitative Coronary Angiography-Based Vessel-Ffr Guided Revascularization – The Fast Iii Trial

血流储备分数或基于3D定量冠状动脉造影的血管FFR指导血运重建——Fast III试验

汇报人：Joost Daemen

LBCT IV

北京时间：3月30日 00:45-1:45

Spironolactone in the Treatment of Heart Failure

螺内酯治疗心力衰竭

汇报人：Frank Edelmann

Efficacy and Safety of Sotatercept in Combined Post- and Pre-Capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction: Results From the Phase 2 Cadence TrialSotatercept

在射血分数保留型心力衰竭相关的毛细血管前后混合性肺动脉高压中的疗效与安全性：2期Cadence试验结果

汇报人：Mardi Gomberg-Maitland

Lung Impedance-Guided Therapy in Heart Failure With Preserved Ejection Fraction: Results of a Randomized Clinical Trial

基于肺阻抗监测指导射血分数保留型心力衰竭治疗：一项随机临床试验结果

汇报人：Michael Kleiner Shochat

Mavacamten in Symptomatic Adolescent Patients With Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout-HCM TrialMavacamten

用于有症状的青少年梗阻性肥厚型心肌病患者：来自3期Scout-HCM试验的结果

汇报人：Joseph William Rossano

LBCT V

北京时间：3月30日 6:00-7:00

Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial

再次外科手术 vs. 经导管瓣中瓣技术治疗二尖瓣生物瓣功能障碍：SURVIV试验

汇报人：Dimytri Siqueira

Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention: A Randomized Controlled Trial

不常规进行经皮冠状动脉介入治疗的经导管主动脉瓣植入术：一项随机对照试验

汇报人：Michiel Voskuil

Protect The Head To Head Trial: Randomized Comparison of Emboliner Embolic Protection Catheter Vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve ReplacementProtect The Head to Head

试验：Emboliner栓塞保护导管与Sentinel脑保护系统在经导管主动脉瓣置换术中的随机对比研究

汇报人：Adam B. Greenbaum

Two-Year Outcomes After Transcatheter Tricuspid Repair Without Cross-over in the Randomized Tri-fr TrialTri-Fr

随机试验中无交叉治疗的经导管三尖瓣修复术后两年结局

汇报人：Erwan Donal

LBCT VI

北京时间：3月30日 22:30-23:30

Heartline Study: A Decentralized Randomized Trial of Apple Watch and iPhone-Facilitated AF Detection and Cardiovascular Outcomes in Older Adults Without Known Atrial FibrillationHeartline

研究：一项基于苹果手表与iPhone的无症状老年人房颤筛查及心血管结局分散式随机试验

汇报人：C. Michael Gibson

Digoxin in Rheumatic Heart Disease: A Multi-Center, Randomized, Double Blind, Placebo-controlled Trial

地高辛用于风湿性心脏病：一项多中心、随机、双盲、安慰剂对照试验

汇报人：Ganesan Karthikeyan

Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction

急性心肌梗死后病情稳定患者停用β受体阻滞剂治疗

汇报人：Joo-Yong Hahn

Effect of Intensive Triglyceride Lowering With Olezarsen on Progression of Coronary Atherosclerosis: A Coronary Cta Substudy of The Essence-TIMI 73b Randomized TrialOlezarsen

强化降低甘油三酯对冠状动脉粥样硬化进展的影响：Essence-TIMI 73b随机试验的冠状动脉CTA亚组研究

汇报人：Nicholas Marston

LBCT VII

北京时间：3月31日 00:45-1:45

Primary Efficacy and Safety Results From the Phase 3 Sirolimus-Coated Balloon For Infra-inguinal Peripheral Arterial Disease (SirPAD) Trial

西罗莫司涂层球囊治疗腹股沟下外周动脉疾病的3期SirPAD试验主要疗效与安全性结果

汇报人：Stefano Barco

Intravascular Ultrasound Guidance For Complex High-Risk Indicated Procedures – The Ivus Chip Trial

血管内超声指导复杂高危有指征手术——Ivus Chip试验

汇报人：Roberto Diletti

03

特色临床研究（FCR）

FCR I

北京时间：3月29日 02:00-03:00

A Prospective Multicenter Registry to Define Coronary Vasomotor Disorders in Ischemia With Nonobstructive Coronary Arteries: Primary Results of Discover Inoca

一项前瞻性多中心注册研究旨在明确非阻塞性冠状动脉缺血中的冠状动脉血管舒缩功能障碍：DISCOVER INOCA研究主要结果

汇报人：Samit M. Shah

Impact of Ivabradine on Orthostatic Intolerance, Quality of Life and Heart Rate in Post-Covid Postural Orthostatic Tachycardia Syndrome: Results From the Recover-Autonomic Trial

伊伐布雷定对新冠后体位性心动过速综合征患者直立不耐受、生活质量及心率的影响：RECOVER-AUTONOMIC试验结果

汇报人：Saibal Kar

Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Sex Differences in Underlying Causes of Myocardial Infarction With No Obstructive Coronary Arteries

应用冠脉光学相干断层扫描与心脏磁共振成像探究非阻塞性冠脉心肌梗死病因的性别差异

汇报人：Harmony R. Reynolds

A Sham Controlled Randomised Trial Evaluating the Safety, Acceptability and Efficacy of Autonomic Neuromodulation Using Trans-Cutaneous Vagal Sensory Stimulation in Uncontrolled Hypertensive Patients

评估经皮迷走神经感觉刺激用于未控制高血压患者自主神经调节的安全性、可接受性与有效性：一项假刺激对照随机试验

汇报人：Ajay K. Gupta

FCR II

北京时间：3月29日 03:30-04:30

Effects of Tirzepatide Compared With Dulaglutide on Expanded Cardiorenal Outcomes

替西帕肽对比度拉糖肽对扩展心肾结局的影响

汇报人：Steven E. Nissen

Prevalence and Clinical Impact of Hypercortisolism in Individuals With Resistant Hypertension: Primary Results From the Momentum Study难治性高血压患者中皮质醇增多症的患病率与临床影响：MOMENTUM研究的主要结果

汇报人：Deepak L. Bhatt

Reliability of CAC=0 to Exclude Coronary Plaque in Diverse Global Cohorts: A Global Probability Study of Coronary Artery Disease (GPS-CAD) Analysis

CAC=0在不同种族队列中排除冠脉斑块的可靠性评估：全球冠状动脉疾病概率研究（GPS-CAD）数据分析

汇报人：Lohendran Baskaran

Community-to-Clinic Linkage Implementation Program to Prevent Hypertension in Barbershops

基于理发店的社区-诊所联动高血压预防计划实施研究

汇报人：Joseph E. Ravenell

FCR III

北京时间：3月30日 02:15-03:15

10-year Follow-up of Clopidogrel Vs Aspirin Monotherapy in Stable Coronary Artery Disease After Percutaneous Coronary Intervention With Drug-eluting Stent

药物洗脱支架经皮冠状动脉介入治疗后，氯吡格雷对比阿司匹林单药治疗稳定型冠状动脉疾病的10年随访

汇报人：Hyo-Soo Kim

Coronary CT Derived Fractional Flow Reserve-guided Management of Patients With Stable CAD: 3-year Outcomes From A Multicentre, Pragmatic, Open-label, Randomised Controlled Trial in China

冠状动脉CT衍生的血流储备分数指导的稳定型冠状动脉疾病患者管理：一项中国多中心、实用性、开放标签、随机对照试验的3年结果

汇报人：唐春香 中国人民解放军东部战区总医院

Role of Screening With Coronary Computed Tomography Angiography in Lipid Management in an Asymptomatic Chinese Population: A Community-Based, Parallel-Group, Open-Label, Randomized Clinical Trial (RESPECT2)

冠状动脉CT血管造影筛查在无症状中国人群血脂管理中的作用：一项基于社区的、平行组、开放标签、随机临床试验（RESPECT2）

汇报人：郭翔中国人民解放军东部战区总医院

Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure对高风险糖尿病患者进行针对性评估以识别未确诊的心力衰竭

汇报人：Daniel Taylor-Sweet

FCR IV

北京时间：3月30日 03:45-04:45

Automated Notifications to Improve Referral and Treatment of Severe Aortic Stenosis and Mitral Regurgitation: Outcomes From the Randomized Alert Trial

自动化通知改善重度主动脉瓣狭窄和二尖瓣反流的转诊与治疗：随机ALERT试验的结果

汇报人：Wayne B. Batchelor

A Randomized Controlled Trial of a Novel Just-in-Time Adaptive Mobile Application Intervention to Reduce Sodium Intake and Blood Pressure in Patients With Hypertension

一项关于新型即时适应性移动应用程序干预以降低高血压患者钠摄入和血压的随机对照试验

汇报人：Michael Dorsch

NOTIFY-HF: A Randomised Pilot Trial of Patient-Facing Heartlogic Alerts in Heart Failure Patients

NOTIFY-HF：一项面向心力衰竭患者的HeartLogic警报的随机试点试验

汇报人：Joseph Assad

MUTTON-HF (Medically Utilized Tailored Traditional Foods to Optimize Nutrition in Heart Failure): A Randomized Controlled Trial of an Indigenous Food is Medicine Intervention

MUTTON-HF（医疗化应用定制传统食物以优化心力衰竭营养）：一项本土食物即药物的干预措施随机对照试验

汇报人：Lauren A. Eberly

FCR V

北京时间：3月30日 6:00-7:00

Two-Year Outcomes of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation: The TRISCEND II Randomized Trial

经导管三尖瓣置换治疗重度三尖瓣反流的两年结果：TRISCEND II 随机试验

汇报人：Vinod H. Thourani

Efficacy and Safety of BHB/HRS-1893 in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From A 12-week Phase 2 Study

BHB/HRS-1893在有症状的梗阻性肥厚型心肌病中的疗效与安全性：一项为期12周的2期研究结果

汇报人：康连鸣 中国医学科学院阜外医院

The Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Non-inferiority Randomized Trial

心房起搏支持在心脏再同步化治疗中的作用：一项非劣效性随机试验

汇报人：Mauro Biffi

Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI

行直接经皮冠状动脉介入治疗的STEMI患者的院前肝素给药

汇报人：Misa Fister